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Figure 1. Molecular Genetics of Spinal Muscular Atrophy
Spinal muscular atrophy (SMA) is an autosomal recessive disease involving degeneration of ␣-motor neurons in the spinal cord anterior horn, leading to progressive muscular atrophy, paralysis, respiratory failure, and infant death. SMA is caused by deletion of the survival motor neuron 1 (SMN1) gene, which encodes the SMN protein.
Humans have two copies of the SMN gene (SMN1 and SMN2), which are located in a 500 kilobase (kb) inverted repeat on chromosome 5q13. In SMA patients, the SMN1 gene is deleted entirely and SMN2 is spliced such that only ‫%52ف‬ of mRNAs are full length, and ‫%57ف‬ of spliced transcripts exclude exon 7. The SMN2 gene product is sufficient to maintain fetal development, but affected individuals manifest the symptoms of SMA early in life and typically die as infants.
is caused by deletion of the survival motor neuron 1 selectivity suggests that a compound could be affecting the promoter of the construct (which is not the same (SMN1) gene, which encodes the SMN protein. Humans have a related copy of the SMN gene, denoted SMN2.
SMN promoter found in human cells) or that it could be modulating the growth rate of the cells. To this end, our Both are located in a 500 kilobase (kb) inverted repeat on chromosome 5q13. In SMA patients, the SMN1 gene compound libraries were also tested on SMN1-minigene-reporter cells. We refer to these cell types as is deleted entirely and SMN2 is spliced such that only ‫%52ف‬ of mRNAs are full length, while ‫%57ف‬ of spliced SMN2-LUC and SMN1-LUC. transcripts exclude the required exon 7. The product of the SMN2 gene is sufficient to maintain fetal developResults ment, but affected individuals manifest the symptoms of SMA early in life and typically die as infants.
We loaded electronic structures for 47,062 compounds physically present and plated in our laboratory into As it has been previously reported that the lack of exon 7 is the major cause of the SMN2 gene producing SLIMS and recorded for each compound the vendor, initial amount purchased, and the location on each plate a nonfunctional, truncated SMN protein (Figure 1 ) [38] , we developed a phenotype-based assay designed to of each compound. We designed SLIMS to support the industry-standard structure data (SD) format. To load detect proper mRNA splicing. In our study, we used an immortalized human cervical carcinoma cell line stably compound data, we performed an initial scan of each SD file to validate that the compounds were correctly expressing a SMN-minigene-reporter reporter system [39] that consists of exons 6 through 8 with intervening labeled and contained the appropriate information. SLIMS can be configured to require mandatory data for introns of either SMN1 or SMN2, which we obtained from Androphy and Zhou (University of Massachusetts each compound, such as the compound's vendor and catalog number. Medical School, Worcester, MA). This construct also contained a gene conferring neomycin resistance, which After we loaded compounds and plate locations into the SLIMS database, we reformatted these electronic guaranteed that all cells growing in medium containing G418 possessed the minigene construct. Luciferase, the plates from 96-well plates (provided by the original vendors) to 384-well plates, which we used for screening reporter gene's product, is only produced when proper splicing (i.e., incorporation of exon 7 in the final mRNA operations. This electronic reformatting operation was accomplished through the use of a simple SLIMS wizard. transcript) occurs. Exclusion of exon 7 results in the luciferase gene being out-of-frame and is therefore not Compound transfers from mother plates, which are delivered from the vendor, to daughter plates, which contranslated.
Over 47,000 compounds were screened using this tain the stock compounds diluted in DMEM, and assay plates, which contain the compounds, and the cells diassay: 20,000 compounds were from a combinatorial chemistry library from ComGenex; 1,040 compounds luted in DMEM are also performed in this fashion. The SMA study was performed over several months were from a National Institute for Neurological Disorders and Stroke library; 2,337 compounds were from our Anand required considerable protocol optimization. To develop the assay, protocols for data analysis needed to be notated Compound Library [40] ; and 23,685 were from our TIC Library. The TIC Library is a composite of comdynamic and flexible, as new analyses and experimental conditions were developed. SLIMS provides rapid methpounds available from TimTec, IBS, and ChemBridge that were selected for specific properties, including natods for generating protocols and allows multiple protocols to be used while loading an assay into the database. ural-product likeness.
Due to the format of our assay, we were required This is especially important during the protocol optimization process, where old data should coexist with to study compounds that produced an effect that was selective for the SMN2-minigene-reporter cells, as nonnewer data from the same assay. SLIMS provides a protocol-creation wizard to indicate the location of posiScreening results, such as those obtained in this SMA screen, typically exhibit a continuous range of activity tive and negative controls and to select the scoring with a Gaussian distribution. There are several methods scheme for normalizing each plate. Scoring systems of selecting active compounds from such a large-scale built into SLIMS include standard "percent enhancescreen. In the threshold approach, a cutoff value is choment" and "percent inhibition" computations. SLIMS is sen for the selection of hits, and the active compounds sufficiently flexible that experiments can be loaded with are confirmed in a repeat experiment, typically involving multiple protocols. This ensures that, if the protocol a dose-response curve. The cutoff criteria for determinchanges during an experiment, all the experimental data ing hits may be based on absolute activity (i.e., 2-fold can be analyzed as a whole. As newly created assay data activity versus control), the distribution (i.e., three stanis added to SLIMS, they can be immediately visualized dard deviations or greater from the mean), or a desired in order to facilitate the optimization process. This is number of compounds to be retested. Other methods especially important for detecting and rejecting failed use a cutoff to select the most active compounds and plates.
then use techniques such as locating structural analogs Visualization of the data generated over time shows to add to the secondary screening. The SMA screening a significant drift in raw luminescence values for the SMA data showed a standard Gaussian distribution, allowing screen (Figure 2 ). This drift was caused by experimental thresholds to be chosen for hit selection ( Figure 2C ). conditions changing from day to day (e.g., light changes, Before the assay results could be analyzed, however, evaporation). This drift emphasizes that placing control we needed to assess the quality of the screening data. data on each plate is a necessity for normalizing data Due to the nature of the luminescence-based screen, taken over long periods of time. Using these controls, the screening data tended to exhibit spatial artifacts. the normalized data exhibits much less drift (Figure 2 ).
These involved row effects, in which certain rows were Percent enhancement of each well compared to the dimmer than others, and edge effects, in which the edge untreated control wells that were placed on each plate of the plate tended to be brighter than the center. This Figure 2C shows that the mean is ative are wells containing only DMSO. The plots generless than zero, namely Ϫ3.8 percent enhancement. In ated by SLIMS are tied into the database, and clicking our assay, the expected mean percent enhancement of on a data point highlights the relevant compound and all tested compounds should be zero net effect in that most tested drugs should not either enhance or inhibit provides a quick way to scan for initial lead compounds. the SMN-minigene reporters. This bias, even though Individual inspection is both desirable and appropriate for small numbers of plates, but when the number subtle and hard to detect by eye, may occlude potential lead compounds. of plates is large, this approach is unwieldy. SLIMS facilitates high-throughput error detection by automatically We used a periodogram technique to automatically detect systematic errors [36] . Given a microtiter plate correcting for detected spatial patterns. To correct data, we locate systematic patterns and remove them by reseeded with random compounds and no robotic errors, spatial patterns are unlikely and, indeed, unexpected. ducing the power of these high-amplitude outliers (Figures 3A-3C) . Thus, high periodogram amplitudes, which SLIMS computes a spatial randomness probability (P random ) for each assay plate. P random is a qualitative measure of are based on a random model, are suppressed. This process makes the assumption that each plate has been the amount of nonrandom spatial patterning appearing on the plate. For example, a P random value of 0.5 indicates generated by a random process. Each well is assumed to be independent of all other wells in the plate. Correlathat the spatial pattern of the observed plate would be recapitulated in one out of every two plates randomly tions discovered between wells are either real assay responses, such as control wells, or some systematic generated with the same mean and standard deviation as the observed plate. Plates that have a P random Յ 0. rected data so that analyses may span both result sets Once compounds were ranked using our scoring mechanism, results of the SMN2-LUC (i.e., SMN2-miniin order to find lead compounds.
We found that in the SMA screen, the main effect gene-reporter) screen were analyzed. A self-organizing map (SOM) [41] was generated through SLIMS by mapcorrected was one in which the left and right portions of the plate had lowered luminescence intensities, probping the structural space of our compound library (Figure 4A) . SOMs have the property that regions closer to ably due to evaporation from the plate edges. Each plate was analyzed, and if a row, column, or edge effect was each other contain more similar compounds than regions farther away. A structural fingerprint is computed located, it was automatically corrected using this technique. As a result of our systematic error correction techfor each compound loaded into the SLIMS database. This fingerprint is binary vector, representing structures nique, low-scoring compounds were slightly boosted in signal, and higher-scoring values were slightly lowered in located within the compound. This vector is primarily intended to speed up substructure searching but has signal ( Figure 3D ). Since we are looking for high-scoring compounds, this slight correction does not significantly the side benefit of being usable to cluster compounds together based on structure. The SOM illustrates that affect the results of our assay. Even so, this technique restored a small collection of compounds that would the Comgenex portion of our library is composed of molecules in densely packed regions of descriptor otherwise have been missed ( Figure 3D ). In general, we combine the results of the corrected and noncorrected space, which is likely due to the combinatorial nature of the library. The lower SOM shows how compounds data when looking for follow-up or lead compounds. Finally, comparing histograms of the corrected and nonthat have greater than 50 percent enhancement span this structural space. As expected, SMN2-LUC active corrected data shows that the corrected mean value, Ϫ0.1, is closer to the expected percent enhancement compounds, shown crosshatched in white, indicate that hits tend to span descriptor space and range from large of zero. The standard deviation of the corrected data is also reduced, which is also expected since removal of stereochemically diverse structures such as aclarubicin to simpler structure compounds like chrysin. Conspatial artifacts should suppress spatially correlated outliers.
versely, if the active compounds had clumped together to analyze the assay response of compounds with related structures. SLIMS performs this by plotting the We found a collection of analogs within the SMN2-LUC SMA hits ( Figure 4B ). All of these were chosen for testing similarity score to a selected compound against the assay response. As seen in Figure 6 , by computing a in the secondary SMN1-LUC (SMN1-minigene-reporter) screen. similarity score between 6,7-dihydroxyflavone and the compound library, a small class of actives was discovEach compound chosen was tested in a 2-fold, 16-point dilution series at a maximal concentration of 10 ered, supporting the active and selective hypothesis. All of the compounds in this class were selected for follow-M in both SMN2-LUC and SMN1-LUC cell lines. We sought compounds that enhanced SMN2 reporter proup secondary screening. Finally, we used a built-in SLIMS module to search duction but not SMN1 reporter production. By querying the SMN2-LUC and SMN1-LUC data, we identified comthe Medline database to identify potential mechanisms that might be influencing SMN2 protein production. This pounds with good SMN2-LUC (SMN2) response and poor SMN1-LUC (SMN1) response, allowing selection procedure greatly accelerates the search relative to the time it would take using a Pubmed web-based interface. of compounds based on SMN2 selectivity.
These compounds were tested in a dilution series in We submitted the active compounds to a Medline search that identified potential mechanisms of action. Each both the SMN2-LUC and SMN1-LUC cell lines. SLIMS has simple wizards, similar to the standard protocol mechanism was ranked based on a statistical analysis of compound-mechanisms pairings in Medline abstracts creation wizard, for rapidly creating dilution series plates [40]. Table 1 identifies a collection of mechanisms that access to results by displaying SLIMS projects and experiments and allowing users to download the specified might be influencing SMN2 reporter production.
results in either Microsoft Excel format documents or as SLIMS ready-to-open databases, as well as handling Future Directions
We are currently testing a world wide web interface to the laboratory inventory and ordering. the SLIMS database. This service allows users to locate the structures of compounds on various plates in the Significance database and to perform substructure and similarity searching to query the library as well as interface to the We have created a powerful software tool for tracking Lab Inventory System. The web service also provides and analyzing chemical screening data. This tool is particularly well suited to chemical genetic screens because it allows for flexible and dynamic analyses 
